APA (7th ed.) Citation

KW, G., J, J., AJ, G., B, L., A, D., E, W., . . . L, v. (2023). Assessment of Quality of Life Among Patients With Recurrent Clostridioides difficile Infection Treated with Investigational Oral Microbiome Therapeutic SER-109: Secondary Analysis of a Randomized Clinical Trial. JAMA network open, 6(1), e2253570. https://doi.org/10.1001/jamanetworkopen.2022.53570

Chicago Style (17th ed.) Citation

KW, Garey, et al. "Assessment of Quality of Life Among Patients With Recurrent Clostridioides Difficile Infection Treated with Investigational Oral Microbiome Therapeutic SER-109: Secondary Analysis of a Randomized Clinical Trial." JAMA Network Open 6, no. 1 (2023): e2253570. https://doi.org/10.1001/jamanetworkopen.2022.53570.

MLA (9th ed.) Citation

KW, Garey, et al. "Assessment of Quality of Life Among Patients With Recurrent Clostridioides Difficile Infection Treated with Investigational Oral Microbiome Therapeutic SER-109: Secondary Analysis of a Randomized Clinical Trial." JAMA Network Open, vol. 6, no. 1, 2023, p. e2253570, https://doi.org/10.1001/jamanetworkopen.2022.53570.